Novel vaccine scores better hepatitis B seroprotection in type 2 diabetes
NEW ORLEANS – An investigational hepatitis B vaccine known as Heplisav-B provided significantly better seroprotection among adults with type 2 diabetes than did a currently licensed vaccine, based on...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Hepatitis | Hepatitis B | Hepatitis Vaccine | Vaccines